Price $1.67 |
Market Cap
95.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.6
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-12.3K
|
FCF
-0.2
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-58.90%
|
ROI
-
|
|
ROA
-55.30%
|
EPS Growth
-61.10%
|
Current Ratio
20.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Arrhythmia Research Technology (HRT) | $6.39 | - | - | 12.5M | Strong Buy |
| Rosetta Genomics Ltd. (USA) (ROSG) | $6.11 | - | - | 39.6M | Strong Buy |
| NuVasive, Inc. (NUVA) | $37.12 | - | - | 1.64B | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.71 | - | - | 59.5M | Strong Buy |
| American Shared Hospital Servi (AMS) | $3.29 | - | - | 14.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
